Chad Price started Mako Medical in 2010, the company started with a small conference room in its garage and now has ten employees and offices worldwide. Today, Mako Medical is an international medical technology leader with hundreds of employees serving patients worldwide.
It was only a matter of time before the company took off. Furthermore, right on schedule, 2019 has been a breakout year for Mako Medical, with new revenue growing 40% year-over-year while integrating new clinical trials data each week.
Price is a medical technology entrepreneur who grew up in the medical field. In his early 20s, he worked for a top medical device company and was tasked with leading the development of new technologies for the company’s products. During this time, he began to realize that there was an opportunity in the medical device industry to develop non-invasive therapies and treatments for patients with chronic diseases like diabetes, heart disease, and asthma.
In 2002, Price founded Intrexon Corporation, a developer of synthetic biology-based technologies. Over time, Intrexon became one of the fastest-growing biotechnology companies in history. However, it all came crashing down when FDA regulators shut it down over concerns about its management structure.
Price said his mistake was not being upfront with investors about his role at Intrexon. At the same time, he simultaneously started Mako Medical, and a company focused on developing and commercializing unique therapies that would be applied to patients’ skin using minimally invasive methods like injection or transdermal patches. Today, Mako Medical has grown to serve over 100 million patients in more than 400 hospitals worldwide and countless private practices and medical facilities.
Original source to learn more: https://www.crunchbase.com/person/chad-price-0f7f